Stockscreener 앱 받기
14.55
0.14%
0.02
시간 외 거래:
14.28
-0.27
-1.86%
전일 마감가:
$14.53
열려 있는:
$14.23
하루 거래량:
367.17K
Relative Volume:
2.38
시가총액:
$102.16M
수익:
$5.75M
순이익/손실:
$-38.96M
주가수익비율:
-1.1668
EPS:
-12.47
순현금흐름:
$-32.63M
1주 성능:
+29.68%
1개월 성능:
+88.96%
6개월 성능:
+92.21%
1년 성능:
+148.72%
1일 변동 폭
$13.75
$15.00
1주일 범위
$10.97
$15.80
52주 변동 폭
$2.92
$15.80
칼라 파마슈티컬스 Stock (KALA) Company Profile
명칭
Kala Bio Inc
전화
781-996-5252
주소
1167 MASSACHUSETTS AVENUE, ARLINGTON, MA
KALA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KALA
Kala Bio Inc
|
14.55 | 102.02M | 5.75M | -38.96M | -32.63M | -12.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
칼라 파마슈티컬스 Stock (KALA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-11 | 개시 | Ladenburg Thalmann | Buy |
| 2022-03-30 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2021-08-06 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-09-14 | 다운그레이드 | Jefferies | Buy → Hold |
| 2020-07-23 | 개시 | Northland Capital | Outperform |
| 2020-06-01 | 재개 | Oppenheimer | Outperform |
| 2020-05-27 | 재확인 | H.C. Wainwright | Buy |
| 2020-03-09 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-12-17 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-03-14 | 개시 | Jefferies | Buy |
모두보기
칼라 파마슈티컬스 주식(KALA)의 최신 뉴스
What data driven models say about KALA BIO Inc.’s futureBuy Signal & Reliable Price Breakout Signals - Newser
KALA BIO Inc. stock trend forecastMarket Weekly Review & AI Powered Buy/Sell Recommendations - Newser
Can KALA BIO Inc. outperform under higher oil pricesPortfolio Risk Report & Daily Profit Focused Screening - beatles.ru
What drives KALA BIO Inc.’s stock pricePortfolio Value Summary & Growth-Oriented Investment Plans - خودرو بانک
Can KALA BIO Inc. weather a recessionJuly 2025 Update & Risk Controlled Swing Trade Alerts - خودرو بانک
Is KALA BIO Inc. forming bullish engulfing patternsQuarterly Profit Summary & Daily Technical Stock Forecast Reports - خودرو بانک
Q3 Earnings Forecast for KALA BIO Issued By Lifesci Capital - Defense World
Will KALA BIO Inc. stock go up soon2025 Momentum Check & Risk Controlled Stock Pick Alerts - Newser
Can KALA BIO Inc. disrupt its industryDollar Strength & Real-Time Stock Price Movement Reports - خودرو بانک
Visual trend scoring systems applied to KALA BIO Inc.Weekly Profit Report & Community Driven Trade Alerts - Newser
How to read the order book for KALA BIO Inc.Dip Buying & Reliable Entry Point Alerts - Newser
Individual investors are KALA BIO, Inc.'s (NASDAQ:KALA) biggest owners and were rewarded after market cap rose by US$28m last week - simplywall.st
KALA BIO, Inc.'s (NASDAQ:KALA) market cap surged US$28m last week, retail investors who have a lot riding on the company were rewarded - Yahoo Finance
What’s KALA BIO Inc.’s historical returnJuly 2025 Highlights & Safe Entry Point Identification - خودرو بانک
Is KALA BIO On The Verge Of A Pivotal Moment With KPI-012? - RTTNews
Smart tools for monitoring KALA BIO Inc.’s price action2025 Risk Factors & AI Forecasted Entry and Exit Points - Newser
Is KALA BIO Inc. showing insider buyingPortfolio Update Summary & Entry Point Confirmation Alerts - 더경남뉴스
Using Python tools to backtest KALA BIO Inc. strategies2025 Winners & Losers & Verified Technical Signals - Newser
Can you recover from losses in KALA BIO Inc.July 2025 Gainers & Technical Pattern Based Buy Signals - Newser
What’s next for KALA BIO Inc. stock priceWeekly Stock Report & Low Drawdown Investment Strategies - Newser
Signal strength of KALA BIO Inc. stock in tech scannersMarket Activity Recap & AI Optimized Trade Strategies - Newser
KALA BIO to Present at H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewswire
Using data tools to time your KALA BIO Inc. exitWeekly Trend Recap & Short-Term Swing Trade Alerts - Newser
Rare Eye Disease Biotech KALA BIO to Present Latest Developments at H.C. Wainwright Conference - Stock Titan
Momentum divergence signals in KALA BIO Inc. chartJuly 2025 Action & Risk Managed Trade Strategies - Newser
Is KALA BIO Inc. a candidate for recovery playMarket Growth Summary & Free Expert Approved Momentum Trade Ideas - Newser
KALA BIO Inc.’s volatility index tracking explainedJuly 2025 PostEarnings & Advanced Swing Trade Entry Plans - Newser
What candlestick patterns are forming on KALA BIO Inc.Weekly Loss Report & High Conviction Trade Alerts - Newser
What’s the analyst consensus on KALA BIO Inc.2025 Price Action Summary & Long-Term Capital Growth Ideas - خودرو بانک
Can KALA BIO Inc. continue delivering strong returns2025 Valuation Update & Trade Opportunity Analysis - خودرو بانک
KALA BIO Promotes President And COO Todd Bazemore To President And CEO - Nasdaq
Kala Bio appoints Todd Bazemore as CEO and director, updates compensation - Investing.com
KALA BIO Appoints Todd Bazemore as President, Chief Executive Officer and Director - The Manila Times
Rare Disease Expert Todd Bazemore Takes Helm at KALA BIO Ahead of Crucial Phase 2b Trial Results - Stock Titan
KALA BIO Soars 12.75% on CHASE Trial Anticipation - AInvest
Statistical indicators supporting KALA BIO Inc.’s strengthWeekly Trade Recap & High Return Trade Opportunity Guides - Newser
칼라 파마슈티컬스 (KALA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):